Form 144 | Lantern Pharma(LTRN.US) Insider Proposes to Sell 291.55K in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 26, $Lantern Pharma(LTRN.US)$ Insider Bios Fund II NT, LP intends to sell 54,597 shares of its common stock on Apr 29, with a total market value of approximately $291.55K.
Form 144 | Lantern Pharma(LTRN.US) Insider Proposes to Sell 2.18 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 26, $Lantern Pharma(LTRN.US)$ Insider Bios Fund II QP, LP intends to sell 407.85K shares of its common stock on Apr 29, with a total market value of approximately $2.18 mil
Form 144 | Lantern Pharma(LTRN.US) Insider Proposes to Sell 666.9K in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 26, $Lantern Pharma(LTRN.US)$ Insider Bios Fund II, LP intends to sell 124.89K shares of its common stock on Apr 29, with a total market value of approximately $666.9K. B
Form 144 | Lantern Pharma(LTRN.US) Insider Proposes to Sell 1.16 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 26, $Lantern Pharma(LTRN.US)$ Insider Bios Fund I QP, LP intends to sell 217.55K shares of its common stock on Apr 29, with a total market value of approximately $1.16 mill
Form 144 | Lantern Pharma(LTRN.US) Insider Proposes to Sell 1.99 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 26, $Lantern Pharma(LTRN.US)$ Insider Bios Fund I, LP intends to sell 371.95K shares of its common stock on Apr 29, with a total market value of approximately $1.99 million
Rakovina Therapeutics Advances Cancer Fight Despite Losses